By implementing a comprehensive improvement program for its organizational and operational functions, one company increased capacity by more than 100% and 50% for two of its biopharmaceutical products.
Thomas L. McGurk
Advertisement
Articles by Thomas L. McGurk
Advertisement
Latest Updated Articles
Ramping Up and Ensuring Supply Capability for BiopharmaceuticalsJanuary 1st 2004
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
2
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
3
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
4
After the Pivot: What In Vivo Cell Therapy Offers, and What It Still Has to Prove
5